The U.S. Food and Drug Administration granted marketing authorization to the EndoRotor System, which provides a minimally invasive way to resect and remove necrotic tissue for patients with walled-off pancreatic necrosis.
The Pancreatic Cancer Action Network has launched an adaptive clinical trial platform that will enroll patients with pancreatic cancer across 15 sites nationwide.
Investigators of the double-blinded randomized controlled trial compared the efficacy of Lactated Ringer’s solution with Normal Saline for acute pancreatitis resuscitation.
Preliminary data suggest that neoadjuvant treatment of resected pancreatic cancer with urelumab plus nivolumab and GVAX was well tolerated and showed some antitumor activity in a small study.
The FDA, CDC, and several gastroenterology societies have partnered to review ways to reduce duodenoscope-associated transmission of carbapenem-resistant Enterobacteriaceae.
Zenocutuzumab is a first-in-class bispecific antibody that binds to HER2 and HER3 receptors, thereby blocking the interaction of HER3 with its ligand neuregulin 1 (NRG1) or NRG1-fusion proteins.
A randomized controlled trial was performed to assess the safety and efficacy of primary precut sphincterotomy to access the bile duct during endoscopic retrograde cholangiopancreatography.
A team of investigators conducted a retrospective study to assess the use of indomethacin as prophylaxis of pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography.
